Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...

StockNews.com started coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2024 financial results on Thursday, March 20, ...

Egg prices again reached a record high in February, as the bird flu continues to run rampant and Easter and Passover approach. The latest monthly Consumer Price Index showed a ...

Renaissance Technologies' 13F reveals shifts in a $67.6B portfolio with notable changes in Palantir, Novo Nordisk, and NVIDIA ...

Soldiers of 11th Engineer Battalion, 2nd Infantry Division, ROK-US Combined Division, had the opportunity to observe a unique ...

The Eighth Army began its portion of Freedom Shield 2025 on March 9, 2025. Freedom Shield is an 11-day exercise ...

Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

MONTREAL, March 11, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight”), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has entered into a ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.